Voyager Acquisition Corp Class A Ordinary Shares (VACH) Stock Price
VACHStock
$1.78−81.28%52W
Market Cap—
P/E27.69x
PEG Ratio—
Div yield—
Beta-0.29
VACH Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-94.59%
Price vs S&P 500 (4W)-13.15%
VGM Score19.82
P/E Ratio (Annual)27.69x
Industry Peers — Biological Products(183)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
VACHVoyager Acquisition Corp Class A Ordinary Shares | — | D | F | $1.78 |
| AMGNAmgen Inc | C | C | B | $442.24 |
| GILDGilead Sciences Inc | C | B | B | $148.77 |
| MRNAModerna, Inc. Common Stock | D | C | A | $158.83 |
| ARGXargenx SE American Depositary Shares | D | A | B | $1019.49 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $211.38 |
| BIIBBiogen Inc. Common Stock | C | D | B | $220.77 |
| BNTXBioNTech SE American Depositary Share | C | C | B | $114.05 |
| NBIXNeurocrine Biosciences Inc | C | B | C | $153.37 |
| EXELExelixis Inc | C | B | B | $56.72 |
| HALOHalozyme Therapeutics, Inc. | C | B | A | $109.32 |
About Voyager Acquisition Corp Class A Ordinary Shares
Voyager Acquisition Corp is a special purpose acquisition company (SPAC) formed to identify, acquire, and operate a business in a target industry. The company seeks to combine with an operating company to create value for shareholders through strategic acquisition and operational improvements.